Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2021 Sep 6;9(9):e002127corr1. doi: 10.1136/jitc-2020-002127corr1

Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor

PMCID: PMC8422479  PMID: 34489336

De Kouchkovsky I, Zhang L, Philip EJ, et al. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer 2021;9:e002127. doi: 10.1136/jitc-2020-002127

This paper has been updated since first published to amend author name ‘Vadim S Koshkin’.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES